Ken Ling
Impact in
- Biochemistry top 10%
- Sulfur Compounds in Biology
-
- COVID-19 Clinical Research Studies
Papers in
-
- COVID-19 Clinical Research Studies 2
- Co-authors
- Dawei Ye (3 shared papers)Haowen Zhang (1 shared paper)Ya‐Qun Zhou (1 shared paper)Fang Men (1 shared paper)Weici Wang (4 shared papers)Chuanqi Cai (2 shared papers)Yi Guo (2 shared papers)Ke Hu (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (1 paper)Frontiers in Public Health (1 paper)Journal of Cardiothoracic and Vascular Anesthesia (1 paper)International Journal of Molecular Medicine (1 paper)Experimental Biology and Medicine (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Ken Ling
7 papers receiving 512 citations
Peers
Comparison fields: 5 of 87
- Biochemistry 47
- Infectious Diseases 92
- Endocrine and Autonomic Systems 33
- Critical Care and Intensive Care Medicine 22
- Cell Biology 82
Countries citing papers authored by Ken Ling
This map shows the geographic impact of Ken Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Ling more than expected).
Fields of papers citing papers by Ken Ling
This network shows the impact of papers produced by Ken Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Ling. The network helps show where Ken Ling may publish in the future.
Co-authors
The 25 scholars most cited alongside Ken Ling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 266 | |
| 2 | 2022 | 98 | |
| 3 | 2020 | 75 | |
| 4 | 2019 | 24 | |
| 5 | 2020 | 23 | |
| 6 | 2020 | 17 | |
| 7 | 2020 | 16 |
About Ken Ling
Ken Ling is a scholar working on Molecular Biology, Infectious Diseases, Biochemistry, Surgery and Neurology, having authored 7 papers that have together received 519 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (2 papers), Sulfur Compounds in Biology (2 papers), COVID-19 Impact on Reproduction (1 paper), Long-Term Effects of COVID-19 (1 paper), Venous Thromboembolism Diagnosis and Management (1 paper), Eicosanoids and Hypertension Pharmacology (1 paper), Cardiovascular Disease and Adiposity (1 paper) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (1 paper). The work is most often cited by research in Biochemistry (47 citations), Infectious Diseases (92 citations), Endocrine and Autonomic Systems (33 citations), Critical Care and Intensive Care Medicine (22 citations) and Cell Biology (82 citations). Ken Ling has collaborated with scholars based in China and United States. Frequent co-authors include Dawei Ye, Haowen Zhang, Ya‐Qun Zhou, Fang Men, Weici Wang, Chuanqi Cai, Yi Guo, Ke Hu, Yuxuan Li and Xiaohong Peng. Their work appears in journals such as Journal of Medicinal Chemistry, Frontiers in Public Health, Journal of Cardiothoracic and Vascular Anesthesia, International Journal of Molecular Medicine and Experimental Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.